Predictive factors of antiretroviral treatment <4 weeks among HIV-infected pregnant women in Cayenne, French Guiana

被引:4
|
作者
Elenga, Narcisse [1 ]
Hanf, Matthieu [2 ]
Nacher, Mathieu [3 ]
机构
[1] Ctr Hosp Cayenne Andree Rosemon, Serv Pediat, Cayenne, French Guiana
[2] Ctr Invest Clin Epedemiol Clin CIC EC Antilles Gu, Cayenne, French Guiana
[3] Coordinat Reg VIH COREVIH Guyane, Cayenne, French Guiana
关键词
human immunodeficiency virus infection; mother to child transmission; antiretroviral treatment < 4 weeks; French Guiana; TO-CHILD TRANSMISSION; RISK-FACTORS; DISEASE PROGRESSION;
D O I
10.1080/09540121.2011.592821
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
French Guiana is the French territory where the HIV epidemic is most preoccupying. In Cayenne, the mother to child HIV transmission rate was 6% in 2006-2008. Despite free testing and treatment, HIV pregnant women often have delayed or insufficient access to care. The aim of this study was to identify predictive factors of antiretroviral treatment <4 weeks in HIV pregnant women in Cayenne (French Guiana) and then to describe their attitudes, practices, and beliefs regarding HIV/AIDS. A case control study was conducted including all deliveries in Cayenne from 2003 to 2010. For each case, a standardized questionnaire including epidemiological, clinical, and biological data was administered. The analysis first described the summary statistics and then bivariate analysis studied the relation of each variable with the outcome. Multivariate analysis adjusted for the confounding factors. Thirty-three women in the first group and 96 in the control group were included in the study. Women born in French Guiana (OR = 5, IC95% = 1.22-20.86, p = 0.027) had a high risk of treatment <4 weeks. The other factors associated with treatment <4 weeks in our study were benefiting from food parcels (OR = 12.72, IC95% = 2.07-78.14, p = 0.006), consulting a traditional healer when sick (OR = 9.86, IC95% = 2.57-37.88, p = <0.001), and drug use (OR = 6.27, IC95% = 1.26-31.13, p = 0.025). These predictive factors should be considered in prevention programs against mother to child transmission of HIV.
引用
下载
收藏
页码:46 / 53
页数:8
相关论文
共 50 条
  • [41] Ensuring HIV-infected pregnant women start antiretroviral treatment: an operational cohort study from Lilongwe, Malawi
    Weigel, Ralf
    Hosseinipour, Mina C.
    Feldacker, Caryl
    Gareta, Dickman
    Tweya, Hannock
    Chiwoko, Jane
    Gumulira, Joe
    Kalulu, Mike
    Mofolo, Innocent
    Kamanga, Esmie
    Mwale, Gertrude
    Kadzakumanja, Angela
    Jere, Edward
    Phiri, Sam
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2012, 17 (06) : 751 - 759
  • [42] Racial/Ethnic Disparities in Antiretroviral Treatment Among HIV-Infected Pregnant Medicaid Enrollees, 2005-2007
    Zhang, Shun
    Senteio, Charles
    Felizzola, Jesus
    Rust, George
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2013, 103 (12) : E46 - E53
  • [43] An investigation of maternal anaemia among HIV infected pregnant women on antiretroviral treatment in Johannesburg, South Africa
    Methazia, Jewelle
    Ngamasana, Emery Ladi
    Utembe, Wells
    Ogunrombi, Modupe
    Nyasulu, Peter
    PAN AFRICAN MEDICAL JOURNAL, 2020, 37 : 1 - 14
  • [44] Retention in care among HIV-infected pregnant and breastfeeding women on lifelong antiretroviral therapy in Uganda: A retrospective cohort study
    Muhumuza, Simon
    Akello, Evelyn
    Kyomugisha-Nuwagaba, Charity
    Baryamutuma, Rose
    Sebuliba, Isaac
    Lutalo, Ibrahim M.
    Kansiime, Edgar
    Kisaakye, Linda N.
    Kiragga, Agnes N.
    King, Rachel
    Bazeyo, William
    Lindan, Christina
    PLOS ONE, 2017, 12 (12):
  • [45] Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility
    Mostashari, F
    Riley, E
    Selwyn, PA
    Altice, FL
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1998, 18 (04): : 341 - 348
  • [46] Time to undetectable viral load after highly active antiretroviral therapy initiation among HIV-infected pregnant women
    Patel, Deven
    CLINICAL INFECTIOUS DISEASES, 2007, 44 (12) : 1647 - 1656
  • [47] FACTORS ASSOCIATED WITH PMTCT UTILIZATION AMONG HIV-INFECTED WOMEN
    Hamahuwa, Mutinta
    Phiri, Yvonnie
    Manyepa, Pauline
    Moyo, Nkumbula
    Mutanga, Jane
    Thuma, Phil
    Moss, William
    Sutcliffe, Catherine
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (04): : 619 - 619
  • [48] Prevalence of antiretroviral therapy treatment failure among HIV-infected pregnant women at first antenatal care: PMTCT Option B plus in Malawi
    Chagomerana, Maganizo B.
    Miller, William C.
    Tang, Jennifer H.
    Hoffman, Irving F.
    Harrington, Bryna J.
    DiPrete, Bethany
    Wallie, Shaphil
    Jumbe, Allan
    Limarzi, Laura
    Hosseinipour, Mina C.
    PLOS ONE, 2018, 13 (12):
  • [49] Factors associated with adherence to antiretroviral therapy for the treatment of HIV-infected women attending an urban care facility
    Aspeling, Heila E.
    van Wyk, Neltjie C.
    INTERNATIONAL JOURNAL OF NURSING PRACTICE, 2008, 14 (01) : 3 - 10
  • [50] Effect of Pregnancy and the Postpartum Period on Adherence to Antiretroviral Therapy Among HIV-Infected Women Established on Treatment
    Henegar, Cassidy E.
    Westreich, Daniel J.
    Maskew, Mhairi
    Miller, William C.
    Brookhart, M. Alan
    Van Rie, Annelies
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 68 (04) : 477 - 480